Estimated cardiac risk associated with macrolides and fluoroquinolones decreases substantially when adjusting for patient characteristics and comorbidities
Linnea A. Polgreen, Benjamin N. Riedle, Joseph E. Cavanaugh, Saket Girotra, Barry London, Mary C. Schroeder, Philip M. Polgreen
Research output: Contribution to journal › Article › peer-review
Dive into the research topics of 'Estimated cardiac risk associated with macrolides and fluoroquinolones decreases substantially when adjusting for patient characteristics and comorbidities'. Together they form a unique fingerprint.